What Analysts Are Saying About DaVita Stock
Portfolio Pulse from Benzinga Insights
Analysts have recently updated their ratings on DaVita (NYSE:DVA), with a mix of bullish and bearish perspectives. The average 12-month price target has increased by 6.3% to $162.0. DaVita, a leading dialysis service provider, shows strong financial metrics but has a high debt-to-equity ratio.
October 07, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DaVita's stock has seen a positive shift in analyst ratings, with an average price target increase to $162.0. The company shows strong financial performance but is burdened by a high debt-to-equity ratio.
The increase in the average price target by 6.3% indicates a positive outlook from analysts. DaVita's strong financial metrics, such as high ROE and net margin, support this view. However, the high debt-to-equity ratio could pose risks, but the overall sentiment is positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100